We are pleased to announce an MoU with JSS Medical College and Academy of Higher Education and Research, Mysuru to work together in the areas of hemoglobinopathies and rare diseases. The aim is to work on collaborative projects to develop affordable and efficient diagnostics, therapeutics, and treatment options.
Related Posts
Wastewater surveillance advocated for COVID tracking
More municipal corporations across the country are now willing to participate in... read more
PhD Admissions – Shortlisted candidates for interview
TIGS PhD admissions (Jan 2023) via AcSIR List of shortlisted candidates for interview Click... read more
The impact of Next Generation Sequencing on human health and agriculture
Next-Generation Sequencing (NGS) denotes high-throughput sequencing in a massively parallel fashion that... read more
Publication: Enrichment of phenotype among biological forms of Anopheles stephensi Liston through establishment of isofemale lines
The insectary team at TIGS along with researchers from Institute of Bioinformatics... read more
‘Not Done With Covid Pandemic Yet’: Experts Say Future Depends On New Variants, Need to be Watchful
“We should still wait to call the Covid pandemic has reached its... read more
Discarded storage containers may be aggravating Bengaluru dengue outbreaks
In this latest piece by Dr. Farah Ishtiaq, Principal Scientist, TIGS in... read more
Key insights of REDRESS 2023 featured in Biospectrum India
Rare Genetic Diseases Research Summit (REDRESS) 2023, an indigenous and recurrent platform... read more
Ignoring wastewater is a wasted opportunity to improve disease response
During the COVID-19 pandemic, wastewater surveillance emerged as a valuable tool to... read more
The pursuit of a cure for hemophilia – Vasanth Thamodaran
History books, from as early as 2nd century AD, indicate knowledge of a... read more
TIGS and ICAR – IIRR sign MoU
📝 TIGS and ICAR - IIRR ink MoU! Climate change presents a significant... read more